Comparative analysis of low-field magnetic resonance imaging in patients with rheumatoid arthritis treated with certolizumab pegol or infliximab.
Shinya HagiwaraHiroto TsuboiYuki KurodaTomonori SawabeNana UematsuFumina KawashimaToshiki SugitaMayu TerasakiFumika HondaMizuki YagishitaYuya KondoTakayuki SumidaIsao MatsumotoPublished in: Modern rheumatology (2022)
The findings of our study suggest that, in patients with RA, CZP might improve BME more effectively than IFX.